NCT04695431View on ClinicalTrials.gov

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

CompletedOBSERVATIONAL
Enrollment

317

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

October 4, 2021

Study Completion Date

October 4, 2021

Conditions
Advanced Systemic MastocytosisAggressive Systemic MastocytosisSystemic Mastocytosis With an Associated Hematological NeoplasmMast Cell Leukemia
Trial Locations (6)

94304

Standford Cancer Center, Palo Alto

02215

Dana Farber Cancer Institute, Boston

Unknown

Medizinische Universitat Wien, Vienna

Universitatmedizin Mannheim, Mannheim

Hospital Virgen del Valle, Toledo

Guy's and St. Thomas' NHS Foundation Trust, London

Sponsors

Collaborators (1)

Analysis Group, Inc.
All Listed Sponsors
collaborator

Analysis Group, Inc.

INDUSTRY

lead

Blueprint Medicines Corporation

INDUSTRY